News | Latest Breaking News Stories & Headlines

Bayer adds $1.37 billion to Roundup litigation reserves

German pharmaceutical and biotechnology group Bayer said today it had set aside an additional €1.2 billion in provisions to address ongoing litigation in the US over weed killer Roundup.

Business • 01 Aug

Bayer continues to grapple with costly US product liability litigation over its weed killer Roundup

Bayer posts smaller than expected drop in Q1 profits

Bayer has today posted a smaller decline in first-quarter adjusted earnings than investors had feared as strong prescription numbers for new drugs offset a drop in its seed businesses, boosting its shares.

Business • 13 May

German pharmaceutical and biotechnology group Bayer acquired Roundup as part of its $63 billion takeover of US agrochemical company Monsanto in 2018

Bayer hit with $2 billion Roundup verdict in Georgia case

Bayer has been ordered by a jury in the US state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms has said.

Business • 24 Mar

Bayer acquired Roundup under the $63 billion takeover of Monsanto in 2018

Bayer tells US it could halt Roundup weedkiller sales

Bayer has told US politicians it could stop selling the popular Roundup weedkiller unless they can strengthen legal protection against product liability litigation, according to a financial analyst and a person close to the matter.

Business • 07 Mar

Bayer has aised the prospect of a return to earnings growth in 2026

Bayer sees improvement in 2026 after decline this year

Bayer has today raised the prospect of a return to earnings growth next year but reiterated that a decline was expected for this year, potentially testing investors' patience with the CEO's turnaround efforts.

Business • 05 Mar

Bayer's shares sink to 20-year low on earnings forecast

Bayer said today that weak agricultural markets mean its earnings are likely to fall further next year, sparking a sharp fall in the German company's shares and piling pressure on its CEO to deliver on his turnaround efforts.

Business • 12 Nov 24

The 3rd US Circuit Court of Appeals in Philadelphia rejected plaintiff David Schaffner's claim

Bayer wins victory in US legal battle against Roundup

Bayer won a legal victory in its fight to limit liability from claims that its Roundup weed killer causes cancer, as a US appeals court said federal law shields the German company from a lawsuit by a Pennsylvania landscaper.

Business • 16 Aug 24

About 165,000 claims have been made in the US against Bayer for personal injuries allegedly caused by Roundup

Judge cuts Bayer $2.25 billion Roundup verdict to $400m

A Pennsylvania judge has slashed a $2.25 billion US verdict against Bayer to $400m for a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller.

Business • 05 Jun 24

Bayer said its third quarter EBITDA fell 31% to €1.685 billion

Bayer says examining break-up options

Bayer is considering spinning off the diversified group's Consumer Health or Crop Science divisions but has ruled out a three-way split as new CEO Bill Anderson seeks to revive its battered share price.

Business • 08 Nov 23

Bayer this its 2023 earnings would be hit by higher costs and the reversal of last year's price boost for its glyphosate-based weedkillers

Bayer sees lower 2023 operating profit due to inflation

Agriculture and healthcare company Bayer said today that its operating earnings would likely decline in 2023, hurt by higher costs and the reversal of last year's price boost for its glyphosate-based weedkillers.

Business • 28 Feb 23

The company said in a statement that it did not admit liability as part of the settlement

Bayer AG makes $698m settlement in US over pollution

Bayer AG has finalised a $698 million settlement with the US state of Oregon to resolve claims that it polluted the environment with chemicals called polychlorinated biphenyls, or PCBs.

Business • 16 Dec 22

Bayer said its crop science division saw an adjusted EBITDA gain of 33.5% to €629m

Bayer beats Q3 profit forecast on strong herbicide sale

Agriculture and pharmaceuticals company Bayer has today reported better-than-expected quarterly earnings as surging demand for its herbicides made up for a decline in sales of its stroke prevention pill Xarelto.

Business • 08 Nov 22

Prices of agricultural commodities have surged amid concern that Russia's attack on Ukraine will disrupt farming there as both countries are major grains exporters

Bayer's farming business drives Q1 earnings beat

Agriculture and pharmaceuticals company Bayer said its quarterly adjusted earnings rose by a better than expected 27.5% on strong gains at its seeds and pesticides business.

Business • 10 May 22

Bayer said its fourth-quarter adjusted EBITDA was flat at €2.4 billion

Bayer targets return to annual profits growth

German diversified group Bayer is aiming for a return to growth in adjusted core earnings this year as higher profit at its agriculture division would likely be tempered by investments in new genetic treatment technologies.

Business • 01 Mar 22

Bayer shares up after first trial win over Roundup

Shares in Bayer rose this morning after the German agricultural and pharmaceuticals firm won its first trial over claims its Roundup weedkiller causes cancer.

Business • 06 Oct 21

Bayer loses appeals case over glyphosate weedkiller

Bayer lost a third appeal against US court verdicts that awarded damages to customers blaming their cancers on use of its glyphosate-based weedkillers, leaving the German drugs and pesticides group to pin hopes for legal relief on the US Supreme Court.

Business • 10 Aug 21

Bayer acquired Roundup as part of $63 billion purchase of Monsanto in 2018

Bayer sticks to $2bn provision after glyphosate ruling

Bayer said today it was not increasing its $2 billion in provisions after a US judge rejected its class action plan to settle future claims related to its Roundup and other glyphosate-based weedkillers.

Business • 27 May 21

Bayer warns that the costs of its settlement over claims its Roundup weedkiller causes cancer would be higher

Bayer takes €9.25 billion writedown

Bayer took impairment charges of €9.25 billion and said the costs of its settlement over claims its Roundup weedkiller causes cancer would be higher as the burden from its takeover of Monsanto mounts.

Business • 03 Nov 20

Bayer is seeking to revive its women's healthcare business.

Bayer buys UK-based biotech KaNDy Therapeutics

Bayer has agreed to acquire British biotech firm KaNDy Therapeutics for an initial $425 million, to strengthen its women's healthcare business with a prospective non-hormonal treatment of menopausal symptoms.

Business • 11 Aug 20

The settlement involves about 125,000 filed and unfiled claims

Bayer agrees to pay $10.9bn to settle Roundup claims

Bayer has agreed to settle thousands of US lawsuits claiming that its widely-used weed killer Roundup caused cancer for as much as $10.9 billion after more than a year of talks, resolving litigation that has hit the company's share price.

Business • 24 Jun 20

Bayer said in April it has been served with cases from 52,500 US plaintiffs who blame Roundup and other glyphosate-based weedkillers for their cancer

Bayer makes progress in settlement talks over Roundup

Bayer said today it had made progress seeking a settlement over claims its glyphosate-based Roundup weedkiller causes cancer, after Bloomberg reported the company reached a verbal agreement on about 50,000 to 85,000 cases.

Business • 25 May 20

Bayer said the economic downturn has prompted it to take a tougher stance in talks to settle claims its glyphosate-based weedkillers cause cancer

Bayer more stringent in glyphosate settlement talks

Bayer said the economic downturn and the need to preserve cash means it is taking a tougher stance in talks to settle claims its glyphosate-based weedkillers cause cancer, even as its earnings rose.

Business • 27 Apr 20

Farmers will not be allowed to use the insecticide, sold under brands Calypso and Biscaya, after April 30 this year

EU bans Bayer pesticide linked to harming bees

The European Commission has today decided not to renew approval for a pesticide linked to harming bees, effectively banning Bayer's insecticide known as thiacloprid.

Business • 13 Jan 20

Bayer is widely expected to eventually settle to buy itself out of the glyphosate litigation wave

Number of glyphosate plaintiffs jumps to 42,700 - Bayer

Bayer said the number of US plaintiffs blaming its glyphosate-based weedkillers for their cancer mushroomed to 42,700 from 18,400 in July, raising the stakes in the group's efforts to reach a settlement.

Business • 30 Oct 19

Shares in Bayer and Lanxess gained 4.2% and 3.8%, respectively, at 0800 GMT after securing a better-than-expected price after months of negotiations

Lanxess, Bayer sell chemical park operator to Macquarie

German chemical groups Bayer and Lanxess have agreed to sell integrated chemical site operator Currenta to Macquarie Infrastructure and Real Assets for an enterprise value of €3.5 billion.

Business • 07 Aug 19